Skip to main content
Fig. 1 | BMC Genomics

Fig. 1

From: Investigating the genomic alteration improved the clinical outcome of aged patients with lung carcinoma

Fig. 1

Landscape of genetic alterations of 217 lung carcinoma samples. A The baseline characteristics of gene-mutated lung carcinoma patients. Prior drug: drug history before sampling. B The distribution of genetic alterations identified in each specimen. C The number of samples having a certain alteration. D The number of T790M mutation in EGFR L858R or 19Del mutated patients who received 1st generation EGFR TKIs treatment before sampling

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us